Analysts at JP Morgan upgraded Dolby Laboratories, Inc. DLB from Neutral to Overweight.
The price target for Dolby Laboratories has been raised from $39.00 to $48.00.
Dolby Laboratories shares have dropped 14.53 percent over the past 52 weeks, while the S&P 500 index has surged 11.58 percent in the same period.
Dolby Laboratories' shares climbed 2.83 percent to $39.20 in pre-market trading.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in